Jacob
Senior Member
- Reaction score
- 44
Breakthrough Research on Modified Citrus Pectin and Galectin-3 for Cardiovascular Disease, Fibrosis and other Inflammatory Conditions
http://www.dreliaz.org/blog/breakth...se-fibrosis-and-other-inflammatory-conditions
http://www.dreliaz.org/blog/breakth...se-fibrosis-and-other-inflammatory-conditions
By binding to the galectin-3 molecules, Modified Citrus Pectin prevents galectin-3 from fostering harmful inflammation, excessive scar tissue build up and abnormal cellular growth. This new discovery shows MCP has enormous potential for prevention and treatment of inflammation and fibrosis related conditions for which there are currently limited or no treatments available. As a pioneer in the field of Modified Citrus Pectin research, I want to emphasize that this new research is truly exciting because Modified Citrus Pectin is turning out to be much, much, more versatile than anyone imagined.